Evolus (EOLS) Gross Margin (2019 - 2026)

Evolus (EOLS) reported Gross Margin of 66.86% for Q1 2026, down 123.0% on a YoY basis from 290.68% in Q1 2025, and up 1.82% quarter-over-quarter from 65.66% in Q4 2025.

Evolus (EOLS) Gross Margin (2019 - 2026) Analysis & Trends

Evolus has reported Gross Margin for 8 years, with the latest figure at 66.86% in Q1 2026.

  • For the quarter ending Q1 2026, Gross Margin fell 123.0% year-over-year to 66.86%; the trailing twelve-month figure through Mar 2026 stood at 66.06% (down 236.0% YoY), and the FY2025 full-year result was 66.33%, down 214.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 66.86%, up from 65.66% in the prior quarter.
  • The five-year high for Gross Margin was 70.89% in Q1 2023, with the low at 57.43% in Q2 2022.
  • Historically, Gross Margin has averaged 65.98% across 5 years, with a median of 66.67% in 2024.
  • Annual changes were most pronounced in 2023 — Gross Margin jumped 1275 bps — and 2025, when it sank 503 bps.
  • Evolus' Gross Margin stood at 62.6% in 2022, then advanced by 2 bps to 63.56% in 2023, then rose by 5 bps to 66.67% in 2024, then fell by 2 bps to 65.66% in 2025, then gained by 2 bps to 66.86% in 2026.
  • The last three Gross Margin figures came in at 66.86% (Q1 2026), 65.66% (Q4 2025), and 66.47% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 49.52%
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 71.66%
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 82.93%
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 49.50%
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 98.31%
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 57.26%
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -293.83%
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 65.25%
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 61.20%
10 Evolus 437.40 Mn 387.61 Mn 48.90 Mn 66.86%

Historic Data

Download Data
DateValue
Mar 31, 2026 66.86%
Dec 31, 2025 65.66%
Sep 30, 2025 66.47%
Jun 30, 2025 65.31%
Mar 31, 2025 68.09%
Dec 31, 2024 66.67%
Sep 30, 2024 68.92%
Jun 30, 2024 70.35%
Mar 31, 2024 68.26%
Dec 31, 2023 63.56%
Sep 30, 2023 69.15%
Jun 30, 2023 70.19%
Mar 31, 2023 70.89%
Dec 31, 2022 62.60%
Sep 30, 2022 60.21%
Jun 30, 2022 57.43%
Mar 31, 2022 61.05%
Dec 31, 2021 54.31%
Sep 30, 2021 56.93%
Jun 30, 2021 56.69%